Log In
BCIQ
Print this Print this
 

VBY-129

  Manage Alerts
Collapse Summary General Information
Company Virobay Inc.
DescriptionReversible inhibitor of cathepsin S
Molecular Target Cathepsin S
Mechanism of ActionCathepsin S inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today